TGA’s Process Patently Not Effective
At the June Senate Estimates I asked several questions of the Therapeutic Goods Association (TGA). I asked what the TGA was doing to help Australians access a potential new antibacterial to overcome antimicrobial resistance, medicinal cannabis, and off-label Ivermectin. What this trio of medicines has in common is that they are not profitable for pharma […]
